Predictive Biosciences Buys OncoDiagnostic Lab
Predictive Biosciences, a Lexington, Mass.-based developer of intervention diagnostic assays for cancer management, has acquired OncoDiagnostic Laboratory, an anatomic pathology and molecular diagnostics lab. No financial terms were disclosed. Predictive Biosciences has raised around $32 million in VC funding from New Enterprise Associates, Kaiser Permanente Ventures, Flybridge Capital Partners and Highland Capital Partners.
8 January 2010•4 mins read
